Page last updated: 2024-09-05

sb 203580 and Mesothelioma

sb 203580 has been researched along with Mesothelioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albelda, SM; Cheng, G; Ching, LM; Fridlender, ZG; Sun, J; Wang, LC	1

Other Studies

1 other study(ies) available for sb 203580 and Mesothelioma

Article	Year
Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan). The Journal of biological chemistry, 2010, Apr-02, Volume: 285, Issue:14 Topics: Antineoplastic Agents; Cells, Cultured; Chemokine CXCL10; Enzyme Inhibitors; Humans; Imidazoles; Immunoblotting; Kidney; Luciferases; Mesothelioma; NF-kappa B; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Nucleotides; Pyridines; Receptor-Interacting Protein Serine-Threonine Kinase 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Xanthones	2010

Article

Year

Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).

The Journal of biological chemistry, 2010, Apr-02, Volume: 285, Issue:14

Topics: Antineoplastic Agents; Cells, Cultured; Chemokine CXCL10; Enzyme Inhibitors; Humans; Imidazoles; Immunoblotting; Kidney; Luciferases; Mesothelioma; NF-kappa B; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Nucleotides; Pyridines; Receptor-Interacting Protein Serine-Threonine Kinase 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Xanthones

2010